Cargando…

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma

Metabolic reprogramming for adaptation to the local environment has been recognized as a hallmark of cancer. Although alterations in fatty acid (FA) metabolism in cancer cells have received less attention compared to other metabolic alterations such as glucose or glutamine metabolism, recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Hayato, Hayata, Yuki, Kawamura, Satoshi, Yamada, Tomoharu, Fujiwara, Naoto, Koike, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265967/ https://www.ncbi.nlm.nih.gov/pubmed/30445800 http://dx.doi.org/10.3390/cancers10110447

Ejemplares similares

Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
por: Matsushita, Yuki, et al.
Publicado: (2021)

Clinico‐histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease
por: Fujiwara, Naoto, et al.
Publicado: (2023)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2023)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
por: Kurosaki, Shigeyuki, et al.
Publicado: (2021)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

The biological role of metabolic reprogramming in pancreatic cancer
por: Suzuki, Tatsunori, et al.
Publicado: (2020)

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
por: Liao, Wenwei, et al.
Publicado: (2022)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
por: Kubota, Naoto, et al.
Publicado: (2020)

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma
por: Suzuki, Hideo, et al.
Publicado: (2021)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
por: Wang, Qingqing, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
por: Soukupova, Jitka, et al.
Publicado: (2021)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2022)

Lipid metabolism reprogramming and its potential targets in cancer
por: Cheng, Chunming, et al.
Publicado: (2018)

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
por: Talapatra, Jyotirmayee, et al.
Publicado: (2023)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
por: Wu, Shuhui, et al.
Publicado: (2023)

Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
por: Tian, Huining, et al.
Publicado: (2020)

Enlarged folds on endoscopic gastritis as a predictor for submucosal invasion of gastric cancers
por: Toyoshima, Osamu, et al.
Publicado: (2021)

Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
por: Kawamura, Satoshi, et al.
Publicado: (2022)

Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
por: Feng, Xiao-Chen, et al.
Publicado: (2023)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
por: Qiao, Xuehan, et al.
Publicado: (2023)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pkrvfgsj1elb4kfnejv8r0e25